Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Siemens Healthineers Ag (SHL.D.DX)

Siemens Healthineers Ag (SHL.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Siemens Healthineers Ag Siemensstrasse 3 Forchheim BY 91301 DEU

P: 913-184-3385

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.

Key Statistics

Overview:

Market Capitalization, $K 40,640,495
Shares Outstanding, K 1,116,804
% of Institutional Shareholders 12.90%

Financials:

Annual Sales, $ 23,375 M
Annual Net Income, $ 2,144 M
Last Quarter Sales, $ 5,402 M
Last Quarter Net Income, $ 449,000 K

Growth:

1-Year Return -28.04%
3-Year Return -33.88%
5-Year Return -23.91%
5-Year Revenue Growth 10.08%
5-Year Earnings Growth 6.41%
5-Year Dividend Growth 3.50%

Per-Share Information:

Most Recent Earnings 0.40 on 02/05/26
Next Earnings Date N/A
Earnings Per Share ttm 1.89
EPS Growth vs. Prev Qtr -23.08%
EPS Growth vs. Prev Year 6.21%
Annual Dividend & Yield (Paid) 0.95 (2.75%)
Annual Dividend & Yield (Fwd) 1.00 (2.75%)
Most Recent Dividend 1.000 on 02/06/26
Next Ex-Dividends Date 02/06/26
Dividend Payable Date 02/10/26
Dividend Payout Ratio 50.26%

SHL.D.DX Ratios

Ratio
Price/Earnings ttm 19.25
Price/Earnings forward 15.29
Price/Earnings to Growth 2.04
Return-on-Equity % 11.09%
Return-on-Assets % 4.58%
Profit Margin % 9.17%
Debt/Equity 0.03
Price/Sales 1.75
Price/Cash Flow 13.43
Price/Book 2.21
Book Value/Share 16.50
Interest Coverage 7.71
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.